ClinConnect ClinConnect Logo
Search / Trial NCT05685745

Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset

Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER, HOUSTON · Jan 6, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The Multisite Inventory of Neonatal-Perinatal Interventions (MINI) trial is studying the outcomes and medical practices for extremely premature infants born at 22 to 23 weeks of pregnancy. This research aims to create a detailed registry that helps doctors and hospitals understand the care provided to these tiny babies and how they are doing after birth. The trial is currently recruiting participants, which includes all infants born within this gestational age, whether they need special care in the neonatal intensive care unit (NICU) or not.

If your baby is born between 22 weeks and 23 weeks and 6 days, or if they are admitted to the NICU after being born at this age, they may be eligible to participate. Centers can also choose to include data for babies born before 22 weeks if they wish. Families can expect that their baby's health information will be collected and used to improve care for future infants in similar situations. This study is important as it helps gather valuable information that can lead to better outcomes for extremely premature infants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All local births with gestational ages of 22 weeks 0 days - 23 weeks 6 days, regardless of pregnancy outcome or neonatal intensive care (NICU) admission; AND
  • All outborn NICU admissions with gestational age at birth of 22 weeks 0 days - 23 weeks 6 days
  • Optional: Centers who desire to include data for NICU admissions of infants born \<22 weeks' gestation may also submit these data.

About The University Of Texas Health Science Center, Houston

The University of Texas Health Science Center at Houston (UTHealth) is a leading academic institution dedicated to advancing health through education, research, and clinical practice. As a prominent sponsor of clinical trials, UTHealth leverages its extensive resources and expertise in biomedical research to facilitate innovative studies aimed at improving patient outcomes. The institution is committed to fostering a collaborative environment that promotes scientific discovery and the translation of research findings into effective healthcare solutions, all while adhering to the highest ethical standards and regulatory guidelines. With a multidisciplinary approach, UTHealth plays a critical role in addressing complex health challenges and enhancing the quality of life in diverse communities.

Locations

Philadelphia, Pennsylvania, United States

San Diego, California, United States

Boston, Massachusetts, United States

Durham, North Carolina, United States

Iowa City, Iowa, United States

Boston, Massachusetts, United States

Cincinnati, Ohio, United States

Atlanta, Georgia, United States

Houston, Texas, United States

Birmingham, Alabama, United States

Houston, Texas, United States

Portland, Oregon, United States

Greenville, North Carolina, United States

Columbus, Ohio, United States

Mobile, Alabama, United States

Uppsala, , Sweden

Birmingham, Alabama, United States

Jacksonville, Florida, United States

Madison, Wisconsin, United States

Cologne, , Germany

Houston, Texas, United States

Shimotsuke, Tochigi, Japan

San Antonio, Texas, United States

San Antonio, Texas, United States

Richmond, Virginia, United States

Uppsala, Uppland, Sweden

San Antonio, Texas, United States

Orlando, Florida, United States

Orange, California, United States

Kawagoe, Saitama, Japan

Shinkawa, Mitaka, Japan

Azumino, Nagano, Japan

Izumi, Osaka, Japan

Tokyo, , Japan

Phoenix, Arizona, United States

Long Beach, California, United States

San Antonio, Texas, United States

Surrey, British Columbia, Canada

La Paz, , Spain

Patients applied

0 patients applied

Trial Officials

Matthew A Rysavy, MD, PhD

Principal Investigator

The University of Texas Health Science Center, Houston

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials